Dose Finding Study of MCI-186 in Acute Ischemic Stroke
| Заболевание | Acute Ischemic Stroke |
|---|---|
| Фаза | Фаза 2 |
| Спонсор | Shionogi |
| Статус | Прекращено |
| Участники | 17 участн. |
| Вмешательство | Continuous infusion high-dose MCI-186, Continuous infusion low-dose MCI-186, Continuous infusion placebo, Approved dosing regimen MCI-186, Approved dosing regimen placebo |
| Дата начала | 17.11.2017 |
| Дата завершения | 14.05.2018 |
| Публикация результатов | 9.01.2025 |
Кратко
To investigate the efficacy and safety of MCI-186 (bolus followed by continuous infusion) in acute ischemic stroke patients through a double-blind, parallel-group comparison with the existing MCI-186 dosing regimen (administration twice daily for 14 days) as the control.
Number of Participants With National Institutes of Health Stroke Scale (NIHSS) Score Improved.
| Continuous Infusion High-dose Group (Group H) | 0 Participants |
|---|---|
| Continuous Infusion Low-dose Group (Group L) | 0 Participants |
| Approved Dosing Regimen Group (Control Group) | 0 Participants |
| Continuous Infusion High-dose Group (Group H) | 2 Participants |
| Continuous Infusion Low-dose Group (Group L) | 0 Participants |
| Approved Dosing Regimen Group (Control Group) | 1 Participants |
Открыть в BENITIONS Открыть на ClinicalTrials.gov
Другие исследования по этому заболеванию
- Closed-loop Deep Brain Stimulation to Treat Refractory Neuropathic Pain — Prasad Shirvalkar, MD, PhD
- Women's Health Initiative Strong and Healthy Study — Fred Hutchinson Cancer Center
- Edaravone-Sodium Ozagrel Comparative Post-Marketing Study on Acute Ischemic Stroke — Shionogi
- Zambia Stroke Unit Study — Johns Hopkins University
- Tracking Post-stroke Walking Improvements From the Clinic Into the Home — Western University of Health Sciences
- Improving How Older Adults at Risk for Cardiovascular Outcomes Are Selected for Care Coord — Weill Medical College of Cornell University